Ligand Pharmaceuticals, Inc. (LGND)
Ligand Pharmaceuticals Market Cap : 5.980B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 5.876B |
| November 16, 2026 | 6.035B |
| November 13, 2026 | 6.176B |
| November 12, 2026 | 6.326B |
| November 11, 2026 | 6.337B |
| November 10, 2026 | 6.284B |
| November 09, 2026 | 6.283B |
| November 06, 2026 | 6.124B |
| November 05, 2026 | 5.980B |
| November 04, 2026 | 6.323B |
| November 03, 2026 | 6.271B |
| November 02, 2026 | 6.141B |
| October 30, 2026 | 6.455B |
| October 29, 2026 | 6.347B |
| October 28, 2026 | 6.376B |
| October 27, 2026 | 6.235B |
| October 26, 2026 | 6.141B |
| October 23, 2026 | 6.046B |
| October 22, 2026 | 6.132B |
| October 21, 2026 | 6.270B |
| October 20, 2026 | 6.103B |
| October 19, 2026 | 5.922B |
| October 16, 2026 | 5.887B |
| October 15, 2026 | 5.946B |
| October 14, 2026 | 5.876B |
| Date | Value |
|---|---|
| October 13, 2026 | 6.046B |
| October 12, 2026 | 6.198B |
| October 09, 2026 | 6.012B |
| October 08, 2026 | 5.876B |
| October 07, 2026 | 5.842B |
| October 06, 2026 | 5.915B |
| October 05, 2026 | 6.111B |
| October 02, 2026 | 6.035B |
| October 01, 2026 | 6.031B |
| September 30, 2026 | 6.222B |
| September 29, 2026 | 6.182B |
| September 28, 2026 | 6.257B |
| September 25, 2026 | 6.006B |
| September 24, 2026 | 5.957B |
| September 23, 2026 | 5.944B |
| September 22, 2026 | 5.946B |
| September 21, 2026 | 5.778B |
| September 18, 2026 | 5.647B |
| September 17, 2026 | 5.671B |
| September 16, 2026 | 5.482B |
| September 15, 2026 | 5.517B |
| September 14, 2026 | 5.591B |
| September 11, 2026 | 5.667B |
| September 10, 2026 | 5.762B |
| September 09, 2026 | 5.738B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Johnson & Johnson | 659.50B |
| Eli Lilly & Co. | 1.301T |
| Bristol Myers Squibb Co. | 121.76B |
| Xeris Biopharma Holdings, Inc. | 3.102B |
| LENZ Therapeutics, Inc. | 100.55M |
Market Cap Related Metrics
| PE Ratio | 133.38 |
| PS Ratio | 24.39 |
| PEG Ratio | 16.89 |
| Price to Book Value | 6.218 |
| Price to Free Cash Flow | 107.71 |
| Price | 299.00 |
| Earnings Yield | 0.75% |
| PEGY Ratio | 16.89 |
| Operating PE Ratio | 169.57 |
| Normalized PE Ratio | 80.74 |